BCLS II Investco, LP

13F Holdings History for NewAmsterdam Pharma Co N.V. - Ordinary Shares, nominal value Euro 0.12 per share (NAMS)

Symbol: NAMS on Nasdaq
Investment type: Equity / Ordinary Shares, nominal value Euro 0.12 per share
Latest Disclosed Ownership: 5.38M shares
Security Ownership: 4.7%

BCLS Fund III Investments, LP ownership in NewAmsterdam Pharma Co N.V. Ordinary Shares, nominal value Euro 0.12 per share (NAMS)

2025-12-04 - BCLS Fund III Investments, LP has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 5.38M shares of NewAmsterdam Pharma Co N.V. Ordinary Shares, nominal value Euro 0.12 per share (NAMS). This represents 4.7% percent ownership of the company. In their previous filing dated 2025-11-07, BCLS II Investco, LP had reported owning 11.4M shares, indicating a decrease of -52.9% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
BCLS Fund III Investments, LP	4.7%	-52.9%	$214M	5.38M	-6,046,148	-52.9%	$39.89	13D/A	12/2/2025	4 Dec 2025 16:30:05
BCLS Fund III Investments, LP	9.99%		$325M	11.4M			$28.44	13D/A	11/5/2025	7 Nov 2025 19:19:31